BioShield II Extends Liability Protection To All Covered Countermeasures
This article was originally published in The Pink Sheet Daily
Executive Summary
“BioShield II” bill from Sens. Hatch and Lieberman is understood to include indemnification to manufacturers of all bioterror countermeasures, not just smallpox therapy. The bill is also understood to include a “wild card” exclusivity provision.